Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions
- 1 April 2008
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 78 (1) , 150-161
- https://doi.org/10.1016/j.antiviral.2008.01.152
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Studies of Reservoir Hosts for Marburg VirusEmerging Infectious Diseases, 2007
- Marburg Virus Infection Detected in a Common African BatPLOS ONE, 2007
- Successful Topical Respiratory Tract Immunization of Primates against Ebola VirusJournal of Virology, 2007
- Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in MonkeysPLoS Pathogens, 2007
- Effective Post-Exposure Treatment of Ebola InfectionPLoS Pathogens, 2007
- A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical TrialClinical and Vaccine Immunology, 2006
- Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear AccumulationJournal of Virology, 2006
- Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino OligomersPLoS Pathogens, 2006
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Outbreake of Marburg virus disease in Johannesburg.BMJ, 1975